{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T14:27:49Z","timestamp":1786544869166,"version":"build-2736575974"},"reference-count":24,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.urolonc.2011.12.012","type":"journal-article","created":{"date-parts":[[2012,9,25]],"date-time":"2012-09-25T22:38:55Z","timestamp":1348612735000},"page":"1054-1059","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Effect of metabolic syndrome on pathologic features of prostate cancer"],"prefix":"10.1016","volume":"31","author":[{"given":"Emil","family":"Kheterpal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse D.","family":"Sammon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mireya","family":"Diaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akshay","family":"Bhandari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quoc-Dien","family":"Trinh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveen","family":"Pokala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pranav","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mani","family":"Menon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piyush K.","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2011.12.012_bib1","first-page":"212","article-title":"Cancer statistics, 2011: The impact of eliminating socioeconomic and racial disparities on premature cancer deaths","volume":"61","author":"Siegel","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.urolonc.2011.12.012_bib2","first-page":"83","article-title":"Rising incidence of prostate cancer in Shanghai, China","volume":"7","author":"Hsing","year":"1998","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.urolonc.2011.12.012_bib3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/oxfordjournals.epirev.a000792","article-title":"Trends and patterns of prostate cancer: What do they suggest?","volume":"23","author":"Hsing","year":"2001","journal-title":"Epidemiol Rev"},{"key":"10.1016\/j.urolonc.2011.12.012_bib4","doi-asserted-by":"crossref","first-page":"s843","DOI":"10.1093\/ajcn\/86.3.843S","article-title":"Obesity, metabolic syndrome, and prostate cancer","volume":"86","author":"Hsing","year":"2007","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.urolonc.2011.12.012_bib5","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1001\/jama.287.3.356","article-title":"Prevalence of the metabolic syndrome among US adults: Findings from the third National Health and Nutrition Examination Survey","volume":"287","author":"Ford","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.urolonc.2011.12.012_bib6","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1089\/met.2008.0065","article-title":"Metabolic syndrome and cancer","volume":"7","author":"Pothiwala","year":"2009","journal-title":"Metab Syndr Relat Disord"},{"key":"10.1016\/j.urolonc.2011.12.012_bib7","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1158\/1055-9965.EPI-10-0112","article-title":"The metabolic syndrome and the risk of prostate cancer under competing risks of death from other causes","volume":"19","author":"Grundmark","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.urolonc.2011.12.012_bib8","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/S0090-4295(02)01881-2","article-title":"Prospective comparison of radical retropubic prostatectomy and robot-assisted anatomic prostatectomy: The Vattikuti Urology Institute experience","volume":"60","author":"Menon","year":"2002","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2011.12.012_bib9","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1097\/01.ju.0000067464.53313.dd","article-title":"Vattikuti Institute prostatectomy: Technique","volume":"169","author":"Menon","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2011.12.012_bib10","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1464-5491.2006.01858.x","article-title":"Metabolic syndrome\u2014a new world-wide definition","volume":"23","author":"Alberti","year":"2006","journal-title":"Diabet Med"},{"key":"10.1016\/j.urolonc.2011.12.012_bib11","first-page":"331","article-title":"Software for optimal matching in observational studies","volume":"7","author":"Bergstralh","year":"1996","journal-title":"Epidemiology"},{"key":"10.1016\/j.urolonc.2011.12.012_bib12","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/(SICI)1097-0215(20000101)85:1<60::AID-IJC11>3.0.CO;2-B","article-title":"International trends and patterns of prostate cancer incidence and mortality","volume":"85","author":"Hsing","year":"2000","journal-title":"Int J Cancer"},{"key":"10.1016\/j.urolonc.2011.12.012_bib13","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.urology.2009.03.013","article-title":"Racial differences in risk of prostate cancer associated with metabolic syndrome","volume":"74","author":"Beebe-Dimmer","year":"2009","journal-title":"Urology"},{"issue":"6 Pt 1","key":"10.1016\/j.urolonc.2011.12.012_bib14","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1097\/01.ju.0000085381.20139.b6","article-title":"Molecular pathways to prostate cancer","volume":"170","author":"Gonzalgo","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2011.12.012_bib15","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.eururo.2007.04.069","article-title":"Obesity and prostate cancer: Epidemiology and clinical implications","volume":"52","author":"Buschemeyer","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2011.12.012_bib16","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.urology.2008.01.084","article-title":"Relationship between serum prostate-specific antigen levels and components of metabolic syndrome in healthy men","volume":"72","author":"Han","year":"2008","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2011.12.012_bib17","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/pros.10140","article-title":"Association between prostate cancer and serum testosterone levels","volume":"53","author":"Zhang","year":"2002","journal-title":"Prostate"},{"key":"10.1016\/j.urolonc.2011.12.012_bib18","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJMoa021423","article-title":"Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults","volume":"348","author":"Calle","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urolonc.2011.12.012_bib19","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/00008469-200308000-00011","article-title":"Interrelationships between plasma testosterone, SHBG, IGF-I, insulin and leptin in prostate cancer cases and controls","volume":"12","author":"Kaaks","year":"2003","journal-title":"Eur J Cancer Prev"},{"key":"10.1016\/j.urolonc.2011.12.012_bib20","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1093\/aje\/kwj320","article-title":"The metabolic syndrome is associated with reduced risk of prostate cancer","volume":"164","author":"Tande","year":"2006","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.urolonc.2011.12.012_bib21","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1073\/pnas.0308671100","article-title":"Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis","volume":"101","author":"Brakenhielm","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.urolonc.2011.12.012_bib22","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/aje\/kwj284","article-title":"Metabolic syndrome predicts prostate cancer in a cohort of middle-aged Norwegian men followed for 27 years","volume":"164","author":"Lund Haheim","year":"2006","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.urolonc.2011.12.012_bib23","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1158\/1055-9965.1646.13.10","article-title":"Metabolic syndrome and the risk of prostate cancer in Finnish men: A population-based study","volume":"13","author":"Laukkanen","year":"2004","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.urolonc.2011.12.012_bib24","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1002\/pros.21364","article-title":"Metabolic syndrome is associated with high grade Gleason score when prostate cancer is diagnosed on biopsy","volume":"71","author":"De Nunzio","year":"2011","journal-title":"Prostate"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143911004728?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143911004728?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T12:12:33Z","timestamp":1786450353000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143911004728"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":24,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S1078143911004728"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2011.12.012","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of metabolic syndrome on pathologic features of prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2011.12.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}